Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Midazolam
Drug ID BADD_D01459
Description Midazolam is a short-acting hypnotic-sedative drug with anxiolytic, muscle relaxant, anticonvulsant, sedative, hypnotic, and amnesic properties.[A173842] It belongs to a class of drugs called _benzodiazepines_. This drug is unique from others in this class due to its rapid onset of effects and short duration of action.[A173842] Midazolam is available by oral, rectal, intranasal, intramuscular (IM), and intravenous (IV) routes and has been used in various biomedical applications, including dentistry, cardiac surgery, and endoscopic procedures as pre-anesthetic medication, and as an adjunct to local anesthesia.[F2977] This drug was initially approved by the US FDA in 1985, and has been approved for various indications since.[FDA label] In late 2018, the intramuscular preparation was approved by the FDA for the treatment of status epilepticus in adults.[FDA label] In May 2019, the nasal spray of midazolam was approved for the acute treatment of distinctive intermittent, stereotypic seizure episodes in patients 12 years of age and older. Midazolam is considered a schedule IV drug in the United States due to the low potential for abuse and low risk of dependence.[L5074]
Indications and Usage **Intravenous** Indicated for promoting preoperative sedation, anxiolysis, anesthesia induction, or amnesia.[F2434] **Intramuscular** Indicated for the treatment of status epilepticus in adults.[FDA label] **Nasal** Indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient’s usual seizure pattern in patients with epilepsy 12 years of age and older.[L6559]
Marketing Status approved; illicit
ATC Code N05CD08
DrugBank ID DB00683
KEGG ID D00550
MeSH ID D008874
PubChem ID 4192
TTD Drug ID D0U6LM
NDC Product Code 0641-6056; 0641-6061; 0641-6063; 0404-9912; 0404-9913; 0404-9915; 72611-741; 0641-6060; 82393-117; 72572-430; 0641-6209; 0641-6210; 17511-115; 51927-0001; 72611-749; 0641-6057; 0641-6190; 50474-500; 51552-1023; 72572-432; 0641-6211; 48087-0098; 52584-059; 12828-0069; 49452-4721; 67763-100; 0641-6059; 63275-9925; 79037-001
UNII R60L0SM5BC
Synonyms Midazolam | Midazolam Maleate | Maleate, Midazolam | Dormicum | Versed | Midazolam Hydrochloride | Hydrochloride, Midazolam | Ro 21-3981 | Ro 21 3981 | Ro 213981
Chemical Information
Molecular Formula C18H13ClFN3
CAS Registry Number 59467-70-8
SMILES CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Visual impairment06.02.10.013--Not Available
Vomiting07.01.07.003--
Wheezing22.03.01.009--
Withdrawal syndrome19.07.06.023; 08.06.02.012--Not Available
Yawning22.12.03.037--Not Available
Mental status changes19.07.01.0010.000131%Not Available
Paradoxical drug reaction08.06.01.0140.000131%Not Available
Injection site coldness12.07.03.023; 08.02.03.023--Not Available
Nasal discomfort22.12.03.0120.000889%Not Available
Musculoskeletal stiffness15.03.05.027--Not Available
Clonic convulsion17.12.03.008--Not Available
Affect lability19.04.01.001--Not Available
Induration08.01.03.020--Not Available
Cardiac disorder02.11.01.003--Not Available
Connective tissue disorder10.04.04.026; 15.06.01.006--Not Available
Mediastinal disorder22.09.03.001--Not Available
Mental disorder19.07.01.002--Not Available
Obstructive airways disorder22.03.01.011--Not Available
Psychotic disorder19.03.01.002--
Pulmonary function test decreased13.19.01.001--Not Available
Upper airway obstruction22.12.03.032--Not Available
Therapeutic response prolonged08.06.01.061--Not Available
The 6th Page    First    Pre   6    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene